Articles

• Biochemical aspects of Parkinson's disease

  Oleh Hornykiewicz

  • Abstract
  • Full Text
  • Full Text (PDF)
• Do dopamine agonists provide neuroprotection?

  Mitsutoshi Yamamoto

  • Abstract
  • Full Text
  • Full Text (PDF)
• Early introduction of dopamine agonists in the long-term treatment of Parkinson's disease

  Norio Ogawa

  • Abstract
  • Full Text
  • Full Text (PDF)
• Should treatment of Parkinson's disease be started with a dopamine agonist?

  Werner Poewe

  • Abstract
  • Full Text
  • Full Text (PDF)
• Classification of fluctuations in patients with Parkinson's disease

  Niall P. Quinn

  • Abstract
  • Full Text
  • Full Text (PDF)
• Neostriatal mechanisms in Parkinson's disease

  Thomas N. Chase, Justin D. Oh, Pierre J. Blanchet

  • Abstract
  • Full Text
  • Full Text (PDF)
• Management of response fluctuationsPractical guidelines

  Ruth Djaldetti, Eldad Melamed

  • Abstract
  • Full Text
  • Full Text (PDF)